4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-002577
Chief Financial Officer sold 30,625 shares at an average $72.44 ($2,218,477)
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-06 | Sale : show line 1 in the form | −1,100 | $70.75 | $77,825 | 486,568 | D |
| 2021-01-06 | Sale : show line 2 in the form | −4,359 | $71.77 | $312,845 | 482,209 | D |
| 2021-01-06 | Sale : show line 3 in the form | −25,166 | $72.63 | $1,827,807 | 457,043 | D |
| Open-market sales · 30,625 sh · avg $72.44 · $2,218,477 | ||||||
Loading xslF345X03/doc4.xml…